Staphylococci Planktonic and Biofilm Environments Differentially Affect Osteoclast Formation

Overview

Journal Inflamm Res

Specialties Allergy & Immunology
Pathology

Date 2023 Jun 17

PMID 37329360

Authors

Elisabeth Seebach

Franziska V Kraus

Tabea Elschner

Katharina F Kubatzky

Affiliations

Soon will be listed here.

Abstract

Introduction: The pathophysiology of chronic implant-related bone infections is characterized by an increase in osteoclast numbers and enhanced bone resorption. Biofilms are a major reason for chronicity of such infections as the biofilm matrix protects bacteria against antibiotics and impairs the function of immune cells. Macrophages are osteoclast precursor cells and therefore linked to inflammation and bone destruction.

Objective And Method: Investigations on the impact of biofilms on the ability of macrophages to form osteoclasts are yet missing and we, therefore, analyzed the effect of Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) planktonic and biofilm environments on osteoclastogenesis using RAW 264.7 cells and conditioned media (CM).

Results: Priming with the osteoclastogenic cytokine RANKL before CM addition enabled the cells to differentiate into osteoclasts. This effect was highest in SE planktonic or SA biofilm CM. Simultaneous stimulation with CM and RANKL, however, suppressed osteoclast formation and resulted in formation of inflammation-associated multinucleated giant cells (MGCs) which was most pronounced in SE planktonic CM.

Conclusion: Our data indicate that the biofilm environment and its high lactate levels are not actively promoting osteoclastogenesis. Hence, the inflammatory immune response against planktonic bacterial factors through Toll-like receptors seems to be the central cause for the pathological osteoclast formation. Therefore, immune stimulation or approaches that aim at biofilm disruption need to consider that this might result in enhanced inflammation-mediated bone destruction.

Citing Articles

DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases.

Anees F, Montoya D, Pisetsky D, Payne C Proc Natl Acad Sci U S A. 2024; 121(11):e2319634121.

PMID: 38442162 PMC: 10945806. DOI: 10.1073/pnas.2319634121.

planktonic but not biofilm environment induces an IFN-β macrophage immune response via the STING/IRF3 pathway.

Seebach E, Sonnenmoser G, Kubatzky K Virulence. 2023; 14(1):2254599.

PMID: 37655977 PMC: 10496530. DOI: 10.1080/21505594.2023.2254599.

References

Muthukrishnan G, Masters E, Daiss J, Schwarz E . Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis. Curr Osteoporos Rep. 2019; 17(6):395-404. PMC: 7344867. DOI: 10.1007/s11914-019-00548-4. View

Rumbaugh K, Sauer K . Biofilm dispersion. Nat Rev Microbiol. 2020; 18(10):571-586. PMC: 8564779. DOI: 10.1038/s41579-020-0385-0. View

Palmieri E, Gonzalez-Cotto M, Baseler W, Davies L, Ghesquiere B, Maio N . Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun. 2020; 11(1):698. PMC: 7000728. DOI: 10.1038/s41467-020-14433-7. View

Zimmerli W, Sendi P . Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol. 2011; 33(3):295-306. DOI: 10.1007/s00281-011-0275-7. View

Christensen G, Simpson W, Younger J, Baddour L, Barrett F, Melton D . Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985; 22(6):996-1006. PMC: 271866. DOI: 10.1128/jcm.22.6.996-1006.1985. View

Souza P, Lerner U . Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation. Front Immunol. 2019; 10:1663. PMC: 6652233. DOI: 10.3389/fimmu.2019.01663. View

Lee Y, Hyung S, Jung H, Kim H, Staerk J, Constantinescu S . The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood. 2007; 111(2):885-93. DOI: 10.1182/blood-2007-03-082941. View

Kubatzky K, Uhle F, Eigenbrod T . From macrophage to osteoclast - How metabolism determines function and activity. Cytokine. 2018; 112:102-115. DOI: 10.1016/j.cyto.2018.06.013. View

Brooks P, Glogauer M, McCulloch C . An Overview of the Derivation and Function of Multinucleated Giant Cells and Their Role in Pathologic Processes. Am J Pathol. 2019; 189(6):1145-1158. DOI: 10.1016/j.ajpath.2019.02.006. View

10.

Xing L, Schwarz E, Boyce B . Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev. 2005; 208:19-29. DOI: 10.1111/j.0105-2896.2005.00336.x. View

11.

Oh E, Lee H, Kim H, Park Y, Seo J, Park J . Serum amyloid A inhibits RANKL-induced osteoclast formation. Exp Mol Med. 2015; 47:e194. PMC: 4673470. DOI: 10.1038/emm.2015.83. View

12.

Mendoza Bertelli A, Delpino M, Lattar S, Giai C, Noto Llana M, Sanjuan N . Staphylococcus aureus protein A enhances osteoclastogenesis via TNFR1 and EGFR signaling. Biochim Biophys Acta. 2016; 1862(10):1975-83. PMC: 6746341. DOI: 10.1016/j.bbadis.2016.07.016. View

13.

Takami M, Kim N, Rho J, Choi Y . Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol. 2002; 169(3):1516-23. DOI: 10.4049/jimmunol.169.3.1516. View

14.

Taubmann J, Krishnacoumar B, Bohm C, Faas M, Muller D, Adam S . Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis. Sci Rep. 2020; 10(1):21020. PMC: 7713370. DOI: 10.1038/s41598-020-77892-4. View

15.

Miron R, Bosshardt D . Multinucleated Giant Cells: Good Guys or Bad Guys?. Tissue Eng Part B Rev. 2017; 24(1):53-65. DOI: 10.1089/ten.TEB.2017.0242. View

16.

Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X . Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009; 15(9):1066-71. PMC: 2755267. DOI: 10.1038/nm.2007. View

17.

Helming L, Gordon S . Molecular mediators of macrophage fusion. Trends Cell Biol. 2009; 19(10):514-22. DOI: 10.1016/j.tcb.2009.07.005. View

18.

Wang Y, Liu X, Dou C, Cao Z, Liu C, Dong S . Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection. J Cell Physiol. 2017; 232(9):2396-2406. PMC: 5485048. DOI: 10.1002/jcp.25774. View

19.

Pereira M, Petretto E, Gordon S, Bassett J, Williams G, Behmoaras J . Common signalling pathways in macrophage and osteoclast multinucleation. J Cell Sci. 2018; 131(11). DOI: 10.1242/jcs.216267. View

20.

Chen Z, Su L, Xu Q, Katz J, Michalek S, Fan M . IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1). J Biol Chem. 2015; 290(50):30163-74. PMC: 4706008. DOI: 10.1074/jbc.M115.663518. View